Rob Arntfield is professor of medicine at Schulich School of Medicine & Dentistry and medical director of the Critical Care Trauma Centre at London Health Sciences Centre (LHSC). (Schulich Medicine & Dentistry Communications)
Rob Arntfield is professor of medicine at Schulich School of Medicine & Dentistry and medical director of the Critical Care Trauma Centre at London Health Sciences Centre (LHSC). (Schulich Medicine & Dentistry Communications) New investor funding will enable Deep Breathe to expand research and development as it inches closer to market launch By Prabhjot Sohal , March 27, 2023 By Prabhjot Sohal , March 27, 2023 Point-of-care lung ultrasound, performed right at the bedside, can be life saving for critically ill patients. It can help diagnose several medical conditions such as congestive heart failure, pneumonia, pleural effusion and pneumothorax much faster than traditional methods and with little discomfort to the patient. But due to challenges in interpreting the images produced through hand-held devices such as smartphones and tablets and lack of training to do so, there is a shortage of clinicians adopting it. However, new smart AI-powered solutions are instilling confidence in point-of-care ultrasound technology, encouraging clinicians to use it and investors to fund it. Deep Breathe , founded by Western's Dr. Rob Arntfield , is one such medical technology company revolutionizing point-of-care lung ultrasounds. "Deep Breathe is providing the missing link in the wider adoption of point-of-care lung ultrasound. With our groundbreaking suite of AI-powered lung ultrasound applications , healthcare providers will be able to make decisions with greater speed, accuracy and objectivity,” said Arntfield, professor of medicine at Schulich School of Medicine & Dentistry and medical director of the Critical Care Trauma Centre at London Health Sciences Centre (LHSC).
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
